Corneal neovascularization

The optical clarity of the cornea is essential for maintaining good visual acuity. Corneal neovascularization, which is a major cause of vision loss worldwide, leads to corneal opacification and often contributes to a cycle of chronic inflammation. While numerous factors prevent angiogenesis within...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Experimental eye research Ročník 202; s. 108363
Hlavní autoři:	Nicholas, Matthew P., Mysore, Naveen
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Elsevier Ltd 01.01.2021
Témata:	Angiogenesis Angiogenesis Inhibitors - therapeutic use Animals Cornea - diagnostic imaging Corneal neovascularization Corneal Neovascularization - diagnosis Corneal Neovascularization - drug therapy Diagnostic Imaging - methods Humans Vascular endothelial growth factor (VEGF) Vascular Endothelial Growth Factor A - antagonists & inhibitors Angiogenesis Corneal neovascularization Vascular endothelial growth factor (VEGF)
ISSN:	0014-4835, 1096-0007, 1096-0007
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Popis
Shrnutí:	The optical clarity of the cornea is essential for maintaining good visual acuity. Corneal neovascularization, which is a major cause of vision loss worldwide, leads to corneal opacification and often contributes to a cycle of chronic inflammation. While numerous factors prevent angiogenesis within the cornea, infection, inflammation, hypoxia, trauma, corneal degeneration, and corneal transplantation can all disrupt these homeostatic safeguards to promote neovascularization. Here, we summarize its etiopathogenesis and discuss the molecular biology of angiogenesis within the cornea. We then review the clinical assessment and diagnostic evaluation of corneal neovascularization. Finally, we describe current and emerging therapies. •Summarizes the etiologies and pathogenesis of corneal neovascularization.•Describes the molecular biology of inflammatory corneal neovascularization.•Reviews clinical assessment and diagnostic imaging of corneal neovascularization.•Discusses current and emerging therapies for corneal neovascularization.
Bibliografie:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23
ISSN:	0014-4835 1096-0007 1096-0007
DOI:	10.1016/j.exer.2020.108363